Sumitomo Mitsui Financial Group, Inc. Bristol Myers Squibb CO Transaction History
Sumitomo Mitsui Financial Group, Inc.
- $3.88 Billion
- Q3 2024
A detailed history of Sumitomo Mitsui Financial Group, Inc. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Sumitomo Mitsui Financial Group, Inc. holds 247,963 shares of BMY stock, worth $14.3 Million. This represents 0.33% of its overall portfolio holdings.
Number of Shares
247,963
Previous 215,856
14.87%
Holding current value
$14.3 Million
Previous $8.96 Million
43.15%
% of portfolio
0.33%
Previous 0.27%
Shares
19 transactions
Others Institutions Holding BMY
# of Institutions
2,537Shares Held
1.47BCall Options Held
31.6MPut Options Held
35M-
Vanguard Group Inc Valley Forge, PA189MShares$10.9 Billion0.18% of portfolio
-
Black Rock Inc. New York, NY159MShares$9.15 Billion0.15% of portfolio
-
State Street Corp Boston, MA92.9MShares$5.36 Billion0.2% of portfolio
-
Jpmorgan Chase & CO New York, NY77.9MShares$4.49 Billion0.33% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA61MShares$3.52 Billion0.61% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $123B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...